Next-Chemx Corp (CHMX) Financials
Newest figures come from the 10-Q for Q2 FY2025, filed Aug 19, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CHMX SEC filings page.
This page shows Next-Chemx Corp (CHMX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Negative equity and financing dependence dominate a business whose reported cash uses remain disconnected from its modestly improved net loss
Between FY2023 and FY2024, the net loss narrowed from-$2.5M to-$2.3M , yet operating cash flow worsened from-$545K to-$921K . The earnings improvement did not translate into better cash conversion, indicating that accounting results and cash generation moved in opposite directions.
Liabilities reached
FY2024 operating and investing cash outflows totaled about
Financial Health Signals
Next-Chemx Corp does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Next-Chemx Corp passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass.
Next-Chemx Corp reported a net loss of $2.3M while operations used $921K of cash. With neither figure positive, the ratio between the two carries no quality signal.
Next-Chemx Corp reported an operating loss of $2.1M against $187K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Next-Chemx Corp's EBITDA was -$353K in Q2 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 12.1% from the same quarter a year earlier. Against the prior quarter it is up 6.1%.
Next-Chemx Corp reported -$456K in net income in Q2 2025. This represents a decrease of 18.8% from the same quarter a year earlier. Against the prior quarter it is up 2.2%.
Next-Chemx Corp earned -$0.02 per diluted share (EPS) in Q2 2025. It is unchanged from the prior quarter.
Not reported for Q2 2025.
Cash & Balance Sheet
Next-Chemx Corp held $22K in cash as of Q2 2025; long-term debt is not reported for that period.
Not reported for Q2 2025.
Not reported for Q2 2025.
Margins & Returns
None of these metrics is reported for Q2 2025.
Capital Allocation
None of these metrics is reported for Q2 2025.
CHMX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2510-Q | Q1'2510-Q | Q4'2410-K/A | Q3'2410-Q/A | Q2'2410-Q/A | Q1'2410-Q/A | Q4'2310-K/A | Q3'2310-Q/A |
|---|---|---|---|---|---|---|---|---|
| SG&A Expenses | N/A | N/A | N/A | $319K-20.8% | $362K-37.7% | $482K+10.4% | N/A | $403K+4.0% |
| Operating Income | -$392K+11.1% | -$415K+20.2% | N/A | -$330K+18.3% | -$440K+24.3% | -$520K-19.0% | N/A | -$403K-4.0% |
| EBITDA | -$353K+12.1% | -$376K+21.8% | N/A | -$291K+27.7% | -$402K+30.8% | -$481K-10.4% | N/A | -$402K-4.0% |
| Interest Expense | $70K+67.1% | $64K+73.7% | N/A | $49K+154.6% | $42K+119.1% | $37K+72.7% | N/A | $19K+42.9% |
| Net Income | -$456K-18.8% | -$466K+16.3% | N/A | -$380K+58.8% | -$383K+3.6% | -$556K-21.5% | N/A | -$923K-129.9% |
| EPS (Basic) | -$0.02-100.0% | -$0.020.0% | -$0.020.0% | -$0.01+66.7% | -$0.010.0% | -$0.020.0% | -$0.020.0% | -$0.03-200.0% |
| EPS (Diluted) | -$0.02 | -$0.020.0% | -$0.020.0% | -$0.01+66.7% | -$0.010.0% | -$0.020.0% | -$0.020.0% | -$0.03-200.0% |
| Diluted Shares (Avg) | 29M | 29M0.0% | N/A | 29M+0.2% | 29M+0.4% | 29M+0.6% | N/A | 28M+1.8% |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, Income Tax.
CHMX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2510-Q | Q1'2510-Q | Q4'2410-K/A | Q3'2410-Q/A | Q2'2410-Q/A | Q1'2410-Q/A | Q4'2310-K/A | Q3'2310-Q/A |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.2M-2.3% | $3.2M+10.2% | $2.8M-2.6% | $3.3M-3.4% | $3.2M-4.5% | $2.9M-13.2% | $2.8M-11.6% | $3.4M+7.2% |
| Current Assets | $698K+13.2% | $665K+206.6% | $221K+57.4% | $695K+195.2% | $617K+165.4% | $217K+39.4% | $140K+177.7% | $235K+7760.5% |
| Cash & Equivalents | $22K+3080.5% | $612-99.4% | $63K+2444.6% | $35K-41.9% | $693-98.8% | $95K-33.4% | $2K-91.3% | $61K+64676.6% |
| Short-Term Investments | $0 | $0 | $77K | $0-100.0% | $0-100.0% | $0 | $0 | $102K |
| Accounts Receivable | N/A | N/A | N/A | $496K | $391K | N/A | N/A | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $7.0M+32.7% | $6.5M+44.6% | $6.1M+56.2% | $5.7M+65.1% | $5.3M+74.4% | $4.5M+77.6% | $3.9M+58.1% | $3.4M+57.8% |
| Current Liabilities | $4.9M+15.4% | $4.8M+15.7% | $3.7M+24.2% | $4.5M+29.7% | $4.3M+40.9% | $4.2M+63.3% | $3.0M+20.1% | $3.4M+57.8% |
| Non-Current Liabilities | $2.1M+105.1% | $1.7M+374.0% | $2.4M+157.1% | $1.2M | $1.0M | $365K | $945K | $0 |
| Total Equity | -$3.8M-88.6% | -$3.4M-104.9% | -$3.4M-209.9% | -$2.4M-5057.4% | -$2.0M-638.9% | -$1.6M-312.4% | -$1.1M-248.6% | -$47K-104.7% |
| Retained Earnings | -$9.2M-24.1% | -$8.8M-24.4% | -$8.8M-35.1% | -$7.8M-43.2% | -$7.5M-63.8% | -$7.1M-70.3% | -$6.5M-76.3% | -$5.5M-71.4% |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
CHMX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2510-Q | Q1'2510-Q | Q4'2410-K/A | Q3'2410-Q/A | Q2'2410-Q/A | Q1'2410-Q/A | Q4'2310-K/A | Q3'2310-Q/A |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$329K+42.3% | -$207K+29.3% | $112K+162.6% | -$171K+12.9% | -$569K-505.1% | -$293K+5.6% | -$178K+60.0% | -$197K-12.1% |
| Depreciation & Amortization | $39K-0.2% | $39K0.0% | $39K-74.3% | $39K+2807.0% | $39K+2807.0% | $39K+2807.0% | $151K+11228.0% | $1K0.0% |
| Financing Cash Flow | $350K-26.3% | $145K-62.3% | $353K+194.2% | $206K+3.0% | $475K+311.1% | $385K-9.2% | $120K-74.7% | $200K+62.5% |
Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.
CHMX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$3.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.06), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Next-Chemx Corp CHMX | FY2024 | N/A | -$2.3M | N/A | $40K | — |
| Crawford United CRAWA | FY2024 | $150.2M | $13.6M | 9.0% | $292.8M | — |
Where Next-Chemx Corp Ranks
Frequently Asked Questions
Is Next-Chemx Corp profitable?
No, Next-Chemx Corp (CHMX) reported a net income of -$2.3M in fiscal year 2024.
What is Next-Chemx Corp's EBITDA?
Next-Chemx Corp (CHMX) had EBITDA of -$2.0M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Next-Chemx Corp's operating cash flow?
Next-Chemx Corp (CHMX) recorded an outflow of $921K in operating cash flow during fiscal year 2024, representing cash used by core business activities.
What are Next-Chemx Corp's total assets?
Next-Chemx Corp (CHMX) had $2.8M in total assets as of fiscal year 2024, including both current and long-term assets.
What is Next-Chemx Corp's current ratio?
Next-Chemx Corp (CHMX) had a current ratio of 0.06 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Next-Chemx Corp's return on assets (ROA)?
Next-Chemx Corp (CHMX) had a return on assets of -82.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
How does Next-Chemx Corp's liquidity compare with its operating cash outflow?
At the end of fiscal year 2024, Next-Chemx Corp (CHMX) held $140K in cash, cash equivalents and investments, and reported an operating cash outflow of $921K over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is Next-Chemx Corp's debt-to-equity ratio negative or not reported?
Next-Chemx Corp (CHMX) has negative shareholder equity of -$3.4M as of fiscal year 2024, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Next-Chemx Corp's Piotroski F-Score?
Next-Chemx Corp (CHMX) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Next-Chemx Corp's earnings high quality?
Next-Chemx Corp (CHMX) reported a net loss of $2.3M while operations used $921K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Next-Chemx Corp cover its interest payments?
Next-Chemx Corp (CHMX) reported an operating loss of $2.1M against $187K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.